Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
OpenUpdated: Oct 30, 2025
Summary
The grant aims to fund clinical trials that evaluate the efficacy and safety of products for new indications or labeling changes to address unmet needs in rare diseases, with the goal of increasing the number of approved treatments. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, local and state governments, and foreign entities. Application details are not specified, but interested parties can contact Kimberly Pendleton at the provided email for more information.
Full Description
Description
The purpose of this opportunity is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
Business e-mail address
Recommended Resource
Grant Writing Services on Fiverr
Top PickStruggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.